CELSR1 inhibitors belong to a class of compounds that modulate the activity of the CELSR1 protein, which is a member of the cadherin EGF LAG seven-pass G-type receptors (CELSR) family. CELSR1 is a crucial component of the planar cell polarity (PCP) pathway, a signaling mechanism that governs the coordinated orientation of cells within the plane of a tissue. This receptor is characterized by a long extracellular domain containing cadherin repeats, EGF-like repeats, and laminin G-like domains, which mediate interactions with other cell surface proteins and the extracellular matrix. The PCP pathway, mediated by CELSR1, plays an essential role in the regulation of various cellular processes, including the orientation and alignment of cells during development, as well as the establishment of tissue architecture. Inhibitors targeting CELSR1 disrupt the receptor's ability to transduce signals in this pathway, leading to altered cell polarity and organization. These compounds can serve as valuable tools in studying the molecular underpinnings of PCP and the role of CELSR1 in cellular alignment and tissue development.
Chemically, CELSR1 inhibitors may exhibit structural diversity, but they often share certain features that allow them to interact with the receptor's transmembrane or extracellular domains. These inhibitors may work by blocking the receptor's ligand-binding capacity, preventing it from undergoing conformational changes necessary for signal transduction. Alternatively, some inhibitors may interfere with downstream signaling components associated with CELSR1, thus interrupting the signal cascade required for maintaining cellular polarity. The inhibition of CELSR1 has profound effects on cellular processes such as cytoskeletal reorganization and the regulation of actin dynamics, both of which are integral to the PCP pathway. Researchers studying these inhibitors use them to dissect the functional domains of CELSR1 and to better understand how cellular orientation is precisely regulated during development and in the maintenance of tissue integrity. By disrupting specific signaling interactions, these inhibitors provide insight into how cells communicate spatially and how deviations in these processes can lead to misregulated tissue patterning.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wnt-C59 | 1243243-89-1 | sc-475634 sc-475634A sc-475634B | 5 mg 10 mg 50 mg | $214.00 $326.00 $1275.00 | 1 | |
Wnt-C59 is a potent inhibitor of Wnt signaling, targeting PORCN, a membrane-bound O-acyltransferase required for Wnt secretion. This could impact CELSR1 pathways indirectly. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
Cyclopamine is a Hedgehog signaling pathway inhibitor, which may indirectly affect pathways involving CELSR1. | ||||||
Vismodegib | 879085-55-9 | sc-396759 sc-396759A | 10 mg 25 mg | $82.00 $158.00 | 1 | |
Vismodegib specifically targets the Hedgehog signaling pathway, potentially influencing CELSR1-related processes. | ||||||
Erismodegib | 956697-53-3 | sc-396280 sc-396280A | 10 mg 100 mg | $255.00 $918.00 | ||
Erismodegib is another Hedgehog pathway inhibitor, which could indirectly impact CELSR1 function. | ||||||
KY02111 | 1118807-13-8 | sc-397043 sc-397043A | 5 mg 25 mg | $79.00 $336.00 | ||
KY02111 promotes cardiomyocyte differentiation by inhibiting Wnt/β-catenin signaling, potentially affecting CELSR1-related pathways. | ||||||
JW 55 | 664993-53-7 | sc-364517 sc-364517A | 10 mg 50 mg | $172.00 $726.00 | ||
JW55 antagonizes Wnt/β-catenin signaling, which might indirectly influence CELSR1 activity. | ||||||
PF 670462 | 950912-80-8 | sc-204180 sc-204180A | 10 mg 50 mg | $198.00 $808.00 | 9 | |
PF-670462 is a CK1δ/ε inhibitor, potentially impacting pathways that intersect with CELSR1 function. | ||||||
IC261 | 186611-52-9 | sc-3561 | 5 mg | $140.00 | 11 | |
IC261 selectively inhibits CK1, which may have indirect effects on CELSR1 through various signaling pathways. | ||||||
Casein Kinase I Inhibitor, D4476 | 301836-43-1 | sc-202522 | 1 mg | $99.00 | 6 | |
D4476 is a casein kinase inhibitor, potentially affecting cellular processes related to CELSR1. | ||||||